Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-04-14 @ 7:24 AM
Study NCT ID:
NCT05395858
Status:
TERMINATED
Last Update Posted:
2023-11-28
First Post:
2022-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Learn More About Treatment With Damoctocog Alfa Pegol, How it is Used in Every Day Practice ("Real-World"), and How Satisfied People Who Receive Damoctocog Alfa Pegol Are in United States (US) Hemophilia Treatment Centers
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-06
Completion Date Type:
ACTUAL
First Submit Date:
2022-04-28
First Submit QC Date:
None
Study First Post Date:
2022-05-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-22
Last Update Post Date:
2023-11-28
Last Update Post Date Type:
ACTUAL